IS5289A - Lyfjagjafarbúnaðir og aðferð til meðhöndlunar á veiru- og örverusýkingum og tæringarheilkennum - Google Patents

Lyfjagjafarbúnaðir og aðferð til meðhöndlunar á veiru- og örverusýkingum og tæringarheilkennum

Info

Publication number
IS5289A
IS5289A IS5289A IS5289A IS5289A IS 5289 A IS5289 A IS 5289A IS 5289 A IS5289 A IS 5289A IS 5289 A IS5289 A IS 5289A IS 5289 A IS5289 A IS 5289A
Authority
IS
Iceland
Prior art keywords
syndromes
viral
corrosion
administration
treatment
Prior art date
Application number
IS5289A
Other languages
English (en)
Icelandic (is)
Inventor
Olga Patricia Giesteira Visser Michelle
Original Assignee
Virodene Pharmaceutical Holdings (Proprietary) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Virodene Pharmaceutical Holdings (Proprietary) Limited filed Critical Virodene Pharmaceutical Holdings (Proprietary) Limited
Publication of IS5289A publication Critical patent/IS5289A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IS5289A 1997-06-13 1999-12-08 Lyfjagjafarbúnaðir og aðferð til meðhöndlunar á veiru- og örverusýkingum og tæringarheilkennum IS5289A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (fr) 1997-06-13 1998-06-09 Dispositifs d'administration de medicaments et methodes pour traiter des infections virales ou microbiennes ou le syndrome de deperissement

Publications (1)

Publication Number Publication Date
IS5289A true IS5289A (is) 1999-12-08

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5289A IS5289A (is) 1997-06-13 1999-12-08 Lyfjagjafarbúnaðir og aðferð til meðhöndlunar á veiru- og örverusýkingum og tæringarheilkennum

Country Status (34)

Country Link
EP (1) EP1011567A1 (fr)
JP (1) JP4531141B2 (fr)
KR (1) KR20010013709A (fr)
CN (1) CN1260703A (fr)
AP (1) AP1629A (fr)
AR (1) AR012970A1 (fr)
AU (1) AU7831598A (fr)
BG (1) BG103997A (fr)
BR (1) BR9810095A (fr)
CA (1) CA2295176A1 (fr)
CZ (1) CZ298510B6 (fr)
EA (1) EA200000011A1 (fr)
EE (1) EE9900562A (fr)
ES (1) ES2161187B1 (fr)
FI (1) FI19992648A (fr)
GB (1) GB2341319B (fr)
HU (1) HUP0003034A2 (fr)
ID (1) ID23516A (fr)
IL (2) IL133396A0 (fr)
IS (1) IS5289A (fr)
LT (1) LT4714B (fr)
LV (1) LV12490B (fr)
NO (1) NO996117L (fr)
NZ (1) NZ501669A (fr)
OA (1) OA11307A (fr)
PL (1) PL196256B1 (fr)
RO (1) RO121252B1 (fr)
SI (1) SI20191A (fr)
SK (1) SK172299A3 (fr)
TN (1) TNSN98086A1 (fr)
TR (1) TR200000540T2 (fr)
WO (1) WO1998056325A1 (fr)
YU (1) YU66099A (fr)
ZA (1) ZA984649B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
EP0626945B1 (fr) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Derives d'acide sulfonique utilises dans le traitement de maladies virales
WO1997022248A1 (fr) * 1995-12-15 1997-06-26 Cryopreservation Technologies Cc Composition destinee a la cryopreservation d'organes et au traitement des infections virales et bacteriennes

Also Published As

Publication number Publication date
YU66099A (sh) 2002-10-18
CZ298510B6 (cs) 2007-10-24
SI20191A (sl) 2000-10-31
GB2341319B (en) 2002-02-27
JP2002511862A (ja) 2002-04-16
BR9810095A (pt) 2001-11-13
EA200000011A1 (ru) 2000-08-28
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
AR012970A1 (es) 2000-11-22
KR20010013709A (ko) 2001-02-26
PL338439A1 (en) 2000-11-06
CA2295176A1 (fr) 1998-12-17
ES2161187B1 (es) 2003-08-16
ID23516A (id) 2000-04-27
NO996117L (no) 2000-02-11
SK172299A3 (en) 2000-09-12
NO996117D0 (no) 1999-12-10
ES2161187A1 (es) 2001-11-16
BG103997A (en) 2001-07-31
CZ9904473A3 (cs) 2001-03-14
EP1011567A4 (fr) 2000-06-28
LV12490A (en) 2000-06-20
CN1260703A (zh) 2000-07-19
TNSN98086A1 (fr) 2005-03-15
NZ501669A (en) 2001-09-28
LV12490B (en) 2000-12-20
AU7831598A (en) 1998-12-30
LT4714B (lt) 2000-10-25
TR200000540T2 (tr) 2000-09-21
AP1629A (en) 2006-07-11
HUP0003034A2 (hu) 2000-12-28
FI19992648A (fi) 2000-02-03
GB9929189D0 (en) 2000-02-02
EP1011567A1 (fr) 2000-06-28
IL133396A (en) 2006-10-05
ZA984649B (en) 1999-12-17
AP9901708A0 (en) 1999-12-31
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
GB2341319A (en) 2000-03-15
WO1998056325A1 (fr) 1998-12-17
IL133396A0 (en) 2001-04-30
EE9900562A (et) 2000-06-15
JP4531141B2 (ja) 2010-08-25

Similar Documents

Publication Publication Date Title
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
ITTO950140A0 (it) Procedimento e sistema di aferesi
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
NO980687D0 (no) System og fremgangsmåte for perfusjon-hypertermibehandling
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO20003048D0 (no) Sammenleggbar rullestol og ledd for rullestol
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK199900790A (da) Fremgangsmåde og anlæg til behandling af mælk
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
DK0815922T3 (da) Fremgangsmåde til afsvovling og decarbonisering
DK0839153T3 (da) Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK91793D0 (da) Fremgangsmaade til overfladebehandling, midler til udoevelse og anvendelsen heraf
NO20004400D0 (no) Tilbakeanropssystem og fremgangsmÕte for Internet-telefon
DK0751132T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO993437L (no) Koplingsanordning og fremgangsmåte til bruk av koplingsanordningen
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO911008L (no) For og fremgangsmaate til fremstilling derav.
IS5713A (is) Blöndur prótín-farnesýlfærsluensíms- og HMG COA afoxunarensímstálma og notkun þeirra til meðhöndlunar á krabbameini